Singson, Krisha Mae P.
HRN: 15-32-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2024
CEFUROXIME 1.5GM (VIAL)
11/16/2024
11/23/2024
IV
1.5 G
Q12 Hrs
PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes